| Q35861003 | Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue |
| Q55326781 | Characterization of visceral and subcutaneous adipose tissue transcriptome in pregnant women with and without spontaneous labor at term: implication of alternative splicing in the metabolic adaptations of adipose tissue to parturition. |
| Q57134369 | Estrogen Receptor 1 (ESR1) Enhances /GLUT4 Expression by a SP1 Cooperative Mechanism |
| Q37125987 | Facilitative glucose transporter type 1 is differentially regulated by progesterone and estrogen in murine and human endometrial stromal cells |
| Q35184288 | Intermediate metabolism in normal pregnancy and in gestational diabetes. |
| Q37119910 | Key developments in endocrine disrupter research and human health |
| Q33598516 | Late pregnancy complications in polycystic ovarian syndrome |
| Q34335027 | Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha |
| Q35214941 | New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring |
| Q26830536 | Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome |
| Q80594479 | Oleoyl-estrone treatment to late pregnant and mid-lactating rats affects the expression of lipid metabolism genes |
| Q36862243 | Pregnancy in polycystic ovary syndrome |
| Q36185223 | Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus |
| Q27024055 | Sex hormones and macronutrient metabolism |
| Q35100131 | The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus |
| Q54121183 | [Hexose transporters in humans: their role in insulin sensitivity of peripheral tissues]. |